A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Subject

Project: Research project

Project Details

StatusActive
Effective start/end date3/19/19 → 8/31/50

Funding

  • Astellas Pharma US, Inc